Pedro Cruz-Nova

Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging

Diana Trujillo-Benítez, Myrna Luna‐Gutiérrez, Guillermina Ferro‐Flores et al. · Molecules · 2022 · 43 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17

Toxicity Assessment of [177Lu]Lu−iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes

Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez et al. · Nanomaterials · 2022 · 18 citations · Full text

Pharmacy, Oncology, Pharmacology +17

The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo

Pedro Cruz-Nova, Michael Schnoor, José Correa‐Basurto et al. · BMC Cancer · 2018 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of ¹⁷⁷Lu-DN(C19)-CXCR4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer

Maydelid Trujillo-Nolasco, Pedro Cruz-Nova, Guillermina Ferro‐Flores et al. · Journal of Biomedical Nanotechnology · 2021 · 16 citations

Medicine, Oncology, Pharmacology +17

Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy

Myrna Luna‐Gutiérrez, Pedro Cruz-Nova, Nallely Jiménez‐Mancilla et al. · International Journal of Molecular Sciences · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17